Crossmark Global Holdings, Inc. Hutchmed (China) LTD Transaction History
Crossmark Global Holdings, Inc.
- $6.02 Billion
- Q2 2025
A detailed history of Crossmark Global Holdings, Inc. transactions in Hutchmed (China) LTD stock. As of the latest transaction made, Crossmark Global Holdings, Inc. holds 50,794 shares of HCM stock, worth $779,179. This represents 0.01% of its overall portfolio holdings.
Number of Shares
50,794
Previous 24,420
108.0%
Holding current value
$779,179
Previous $367,000
108.17%
% of portfolio
0.01%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding HCM
# of Institutions
62Shares Held
6.07MCall Options Held
0Put Options Held
0-
Schroder Investment Management Group London, X02.58MShares$39.6 Million0.03% of portfolio
-
Allianz Asset Management Gmb H Munich, 2M925KShares$14.2 Million0.02% of portfolio
-
State Street Corp Boston, MA329KShares$5.04 Million0.0% of portfolio
-
Aia Group LTD Hong Kong, K3315KShares$4.84 Million0.11% of portfolio
-
Goldman Sachs Group Inc New York, NY289KShares$4.44 Million0.0% of portfolio
About HUTCHMED (China) Ltd
- Ticker HCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 172,955,008
- Market Cap $2.65B
- Description
- HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...